Lupin on Saturday announced that it has received an approval from US Food and Drug Administration (USFDA) for the launch of Mirabegron extended-release tablets, 25 mg, in the United States.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
